Class | Relative weight loss | Side Effects | Therapeutic Considerations |
Gastrointestinal lipase inhibitor: (orlistat) | ↓ | Loose stools, GI upset, rare liver failure | Oral medication, decreases fat absorption, may require vitamin supplementation |
GLP-1 receptor agonist: (liraglutide 3.0 mg) | ↓↓ | Nausea, GI upset, rare gallstones and pancreatitis | Subcutaneous injectable, increases satiety |